We are live on ! Find out more
WE

Wealth Effects Portfolio holdings

AUM $282M
1-Year Est. Return 62.81%
This Fund
S&P 500
This Quarter Est. Return
+15.45%
1 Year Est. Return
+62.81%
3 Year Est. Return
+160.11%
5 Year Est. Return
10 Year Est. Return
AUM
$271M
AUM Growth
+$5.11M
Cap. Flow
-$23.7M
Cap. Flow %
-8.72%
Top 10 Hldgs %
44.97%
Holding
240
New
13
Increased
55
Reduced
117
Closed
23

Top Buys

Rank Stock Value
1
UTG icon
Reaves Utility Income Fund
UTG
+$678K
2
NEE icon
NextEra Energy
NEE
+$468K
3
ENVX icon
Enovix
ENVX
+$451K
4
ARM icon
Arm
ARM
+$392K
5
MU icon
Micron Technology
MU
+$367K

Top Sells

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$6.28M
2
MPC icon
Marathon Petroleum
MPC
+$3.49M
3
AVDL
Avadel Pharmaceuticals
AVDL
+$2.27M
4
NVDA icon
NVIDIA
NVDA
+$1.93M
5
AAPL icon
Apple
AAPL
+$1.19M

Sector Composition

Rank Sector Weight
1 Technology 23.65%
2 Healthcare 23.24%
3 Communication Services 7.75%
4 Financials 7.02%
5 Consumer Discretionary 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STXS icon
201
Stereotaxis
STXS
$140M
$188K 0.07%
72,060
+2,500
+4% +$5.94K
ET icon
202
Energy Transfer Partners
ET
$70.3B
$169K 0.06%
10,714
SCYX icon
203
SCYNEXIS
SCYX
$39.3M
$168K 0.06%
14,313
-375
-3% -$5.3K
ETJ
204
Eaton Vance Risk-Managed Diversified Equity Income Fund
ETJ
$565M
$157K 0.06%
18,822
ALT icon
205
Altimmune
ALT
$552M
$150K 0.06%
+14,700
New +$150K
RXRX icon
206
Recursion Pharmaceuticals
RXRX
$1.6B
$150K 0.06%
+15,000
New +$167K
CATX icon
207
Perspective Therapeutics
CATX
$336M
$140K 0.05%
11,750
-250
-2% -$2.13K
BYRN icon
208
Byrna Technologies
BYRN
$76.5M
$139K 0.05%
10,000
ONDS icon
209
Ondas Inc
ONDS
$4.52B
$138K 0.05%
142,500
-15,500
-10% -$20.4K
BCS icon
210
Barclays
BCS
$93.3B
$94.5K 0.03%
10,000
VVR icon
211
Invesco Senior Income Trust
VVR
$457M
$92.9K 0.03%
21,705
-4,960
-19% -$20.6K
ICCC icon
212
ImmuCell
ICCC
$98.9M
$81.7K 0.03%
15,417
HYFM icon
213
Hydrofarm Holdings
HYFM
$3.15M
$72.4K 0.03%
6,700
AKBA icon
214
Akebia Therapeutics
AKBA
$327M
$49.4K 0.02%
27,000
-2,500
-8% -$4K
CCLD icon
215
CareCloud
CCLD
$92.2M
$15K 0.01%
+12,932
New +$17.4K
CURI icon
216
CuriosityStream
CURI
$141M
$12.8K ﹤0.01%
12,001
+500
+4% +$281
HYZN
217
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
$11.1K ﹤0.01%
300
ADBE icon
218
Adobe
ADBE
$84.3B
-10,532
Closed -$6.28M
ED icon
219
Consolidated Edison
ED
$41.6B
-4,393
Closed -$400K
HFXI icon
220
NYLI FTSE International Equity Currency Neutral ETF
HFXI
$1.99B
-10,110
Closed -$251K
HOLX
221
DELISTED
Hologic
HOLX
-3,500
Closed -$250K
IRDM icon
222
Iridium Communications
IRDM
$5.05B
-7,500
Closed -$309K
IYW icon
223
iShares US Technology ETF
IYW
$24B
-2,430
Closed -$298K
LPCN icon
224
Lipocine
LPCN
$18.1M
-14,639
Closed -$40.8K
MPC icon
225
Marathon Petroleum
MPC
$91.2B
-23,500
Closed -$3.49M

Similar funds

Wealth Effects's Q1 2024 Portfolio in Review

As of Q1 2024, Wealth Effects held 240 positions worth $271M, up 1.9% from $266M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Wealth Effects withdrew a net $23.7M in Q1 2024, closing 23 positions and reducing 117 holdings. Its most notable exit was Adobe, an estimated $6.28M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Wealth Effects opened a new position in Arm worth $462K.

  • Wealth Effects's largest Q1 2024 buy was Arm: 3,700 shares worth $462K.
  • Wealth Effects added most to Reaves Utility Income Fund in Q1 2024, an estimated $678K increase.
  • Wealth Effects's biggest Q1 2024 reduction was Avadel Pharmaceuticals, cutting an estimated $2.27M.
  • Wealth Effects fully exited Adobe in Q1 2024, selling an estimated $6.28M.
  • Wealth Effects's ten largest holdings make up 45% of its $271M portfolio in Q1 2024.
  • Wealth Effects opened 13 new positions and closed 23 in Q1 2024.
  • Wealth Effects's portfolio value rose 1.9% quarter-over-quarter to $271M.

Based on Wealth Effects's 13F filing for Q1 2024, filed 22 Apr 2024.